Biodelivery Sciences International (NASDAQ:BDSI): Sirgo Mark A (President and CEO) purchased 1,000 shares at a price of $4.19.

BioDelivery Sciences International, Inc., is a specialty pharmaceutical company that is utilizing licensed and owned proprietary drug delivery technologies to develop and commercialize new formulations of proven therapeutics.

To achieve total return through capital appreciation and income by employing a global equity strategy (investing in 35 to 45 equity securities with a market capitalization of USD5 billion or greater within those countries in the MSCI World Index) and an em

A biopharmaceutical company, which is focused on discovering, developing, and commercializing small molecule drugs to extend and enhance the lives of patients with severe medical conditions, including cancer and chronic inflammatory diseases.

Alex Fredricks has a degree in business and is an avid day-trader. Alex's experience and love for the game of the markets is shown not only in his posts, but the post he helps edit for other authors on our staff.